Estimation bias in survival data within clinical trials that use adaptive seamless designs

Por Khan, Josephine, Kimani, Peter, Stallard, Nigel, Glimm, Ekkehard
Publicado no Trials (2015)

Practical implementation of an adaptive phase I/II design in chronic myeloid leukaemia: evaluating both efficacy and toxicity using the EffTox design

Por Khan, Josephine, Yap, Christina, Clark, Richard, Fenwick, Nicola, Marin, David
Publicado em 2013

Implementation of adaptive dose-finding designs in two early phase haematological trials: clinical, operational, and methodological challenges

Por Yap, Christina, Craddock, Charlie, Collins, Graham, Khan, Josephine, Siddique, Shamyla, Billingham, Lucinda
Publicado em 2013

Prognostic value of monitoring a candidate immunophenotypic leukemic stem/progenitor cell population in patients allografted for acute myeloid leukemia

Por Bradbury, Charlotte, Houlton, Aimee E, Akiki, Susanna, Gregg, Richard, Rindl, Max, Khan, Josephine, Ward, Janice, Khan, Naeem, Griffiths, Mike, Nagra, Sandeep, Hills, Robert, Burnett, Alan, Russell, Nigel, Vyas, Paresh, Grimwade, David, Craddock, Charles, Freeman, Sylvie D.
Publicado no Leukemia (2014)

Tolerability and Clinical Activity of Post-Transplantation Azacitidine in Patients Allografted for Acute Myeloid Leukemia Treated on the RICAZA Trial

Por Craddock, Charles, Jilani, Nadira, Siddique, Shamyla, Yap, Christina, Khan, Josephine, Nagra, Sandeep, Ward, Janice, Ferguson, Paul, Hazlewood, Peter, Buka, Richard, Vyas, Paresh, Goodyear, Oliver, Tholouli, Eleni, Crawley, Charles, Russell, Nigel, Byrne, Jenny, Malladi, Ram, Snowden, John, Dennis, Mike
Publicado no Biol Blood Marrow Transplant (2016)